News list for "02197"

Hong Kong biomedical stocks continued to weaken in the afternoon, Clover Bio (02197.HK) fell more than 14%, Beihai Kangcheng (01228.HK) fell nearly 9%, Kolombote Bio (06990.HK), Konoya (02162.HK), Konoya (02162.HK) fell more than 6%,...

Hong Kong biomedical stocks continued to weaken in the afternoon, clover biological (02197.HK) fell more than 14%, Beihai Kangcheng (01228.HK) fell nearly 9%, Kolombote biological (06990.HK), Conoya (02162.HK), Conoya (02162.HK) fell more than 6%, WuXi Peijino (02126.HK), Jiahe biological (06998.HK) fell more than 5%.

clock
2025-08-27 05:15:49
港股生物医药股午后持续疲软,三叶草生物(02197.HK)跌超14%,北海康成(01228.HK)跌近9%,科伦博泰生物(06990.HK)、康诺亚(02162.HK)、康诺亚(02162.HK)跌超6%,...

港股生物医药股午后持续疲软,三叶草生物(02197.HK)跌超14%,北海康成(01228.HK)跌近9%,科伦博泰生物(06990.HK)、康诺亚(02162.HK)、康诺亚(02162.HK)跌超6%,药明巨诺(02126.HK)、嘉和生物(06998.HK)跌超5%。

clock
2025-08-27 05:15:49
Hong Kong biomedical stocks continued strong outbreak again, clover biological (02197.HK) rose nearly 24%, pioneering pharmaceutical (09939.HK) rose more than 20%, Lepu biological (02157.HK), heart medical (02160.HK) rose more than 10%, Kolombotai biological (...

Hong Kong biomedical stocks continued strong outbreak again, clover biological (02197.HK) rose nearly 24%, pioneering pharmaceutical (09939.HK) rose more than 20%, Lepu biological (02157.HK), heart medical (02160.HK) rose more than 10%, Kolombotai biological (06990.HK) rose more than 8.5%.

clock
2025-07-17 02:10:38
港股生物医药股延续强势再度爆发,三叶草生物(02197.HK)涨近24%,开拓药业(09939.HK)涨超20%,乐普生物(02157.HK)、心通医疗(02160.HK)均涨超10%,科伦博泰生物(...

港股生物医药股延续强势再度爆发,三叶草生物(02197.HK)涨近24%,开拓药业(09939.HK)涨超20%,乐普生物(02157.HK)、心通医疗(02160.HK)均涨超10%,科伦博泰生物(06990.HK)涨超8.5%。

clock
2025-07-17 02:10:38
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.